chrisvoncsefalvay/vaers-outcomes huggingface dataset:
A consumer posted the information on a website, that reported by a mother concerning her daughter who in 2007 was vaccinated with the first dose of GARDASIL (lot# not reported). She was going in for her boosters and the mother rejected all extra dose of GARDASIL. A few weeks after the first vaccination the mother noticed her daughter's neck twitching sharply to one side randomly. She also complained of numbness in her fingers and toes and complained of joint and muscle pains. The mother researched it online a bit and read a website that said teens may develop a tic in this time in their life but it shouldn't last long. The mother took her daughter to the doctors a few weeks later and all kinds of tests were eventually run. Everything came back normal. The mother found that her daughter twitches started a few weeks after she was injected with the GARDASIL vaccine. Researching the effects of the vaccine and more into this drug she was undoubtedly convinced that this was the culprit. She received the "D lot" (the lot number with letter ender). This lot specifically has problems as stated in a credible website. The mother stated again that daughter only received one shot vaccine. No further information is available.
7-16-15 (L) delt. redness and pain. 7-17-15 (5 AM) H/A-vomiting-fever-body aches. She had wellness visit 7/16-no other recent illness.
Chills; Injection site pain; light headed approximately 6 hours after the shot was administered; inappropriate schedule of drug administered; This is a spontaneous report from a non-contactable consumer, the patient. An 89-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the right arm on an unknown date in Feb2021 (at the age of 89-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not take any concomitant medications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) in the right arm on an unknown date in Feb2021 as a single dose for COVID-19 immunisation. On 18Feb2021, the patient experienced chills, injection site pain and light headed approximately 6 hours after the shot was administered. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event chills, injection site pain and light headed was resolved on an unknown date in Feb2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
after first injection I began having  the worst G.I symptoms. Cramping/diarrhea  abodemin pain . Symptoms like diverticulitis.  Seconds injection same symptoms.  8 wks later still having symptoms.
This case was reported by a pharmacist via call center representative and described the occurrence of injection site swelling in a 45-year-old female patient who received BOOSTRIX. On 27th February 2015, the patient received BOOSTRIX (intramuscular) .5 ml. In March 2015, less than a week after receiving BOOSTRIX, the patient experienced injection site swelling, injection site nodule, injection site warmth and injection site erythema. On an unknown date, the outcome of the injection site swelling, injection site nodule, injection site warmth and injection site erythema were not recovered/not resolved. The reporter considered the injection site swelling, injection site nodule, injection site warmth and injection site erythema to be probably related to BOOSTRIX. Additional information: The patient experienced swelling, redness, and a knot under the skin at the injection site. It is also warm to the touch. The events were all ongoing at the time of reporting.
Chills, fever, thready pulse, decreased BP leading to transport via ambulance on 12/18/2020 to hospital and admission from ER to hospital for sepsis, hospitalization and discharge on 12/22/2020.
Fever up to 105.2, body jerking, facial swelling with rash and noisy breathing per Mom. Taken to urgent care the same day and transferred to ED. Treated with Orapred now and discharged on Orapred for three days with Benadryl.
At 0940 employee received both injections, right after second injection employee complaining nausea, the stated his vision was changing only seeing white, employee became diaphoretic, pale, blood pressure dropped, BP 70/52, P 48 ( which employee states he runs lower due to being a runner). RN placed 02 2 liters, continued to monitor employee, ice pack provider, employee remained alert and orientated, responding to questions. 0950 BP rechecked 94/60, employee remained alert, vision back to normal. Medical continued to monitor employee till 10:30, remained stable, and asymptomatic during the remainder of his time in medical.
About 10 minutes after giving vaccine, client complained of palpitations and racing heart. Vitals were taken and heart rate was slightly elevated at 109 beats/minute. I had patient rest in a chair, taking deep slow breaths while I contacted primary care provider in clinic. Provider agreed to see patient at that time. Client was transferred to a wheelchair, started to complain of weakness, and responses to prompts were slower than usual. This nurse (person reporting adverse event) was on the phone with the ER to give report before taking patient to ER (at the next door hospital). Patient slumped in wheelchair and became unresponsive. Code was called and many healthcare staff attended to patient. Patient was safely transferred to hospital ER.
Vaccine administered on 5/22/23 and 6/19/23 had a beyond use date of 3/22/23 (thawed and kept in refrigerator since 01/25/23
the reporter is hesitant about getting the 2nd dose of his Shingrix vaccine after his reaction, the 6 month window for the second dose has passed.; Experience hives on his hands and torso; Swelling around his lips; Insomnia; This case was reported by a consumer via call center representative and described the occurrence of hives in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis and prednisone for hives and lip swelling.   On 28th June 2021, the patient received the 1st dose of Shingrix (intramuscular) 50 µg. On an unknown date, the patient received the 2nd dose of Shingrix. On 29th June 2021, the patient started prednisone at an unknown dose and frequency. In June 2021, less than a day after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced hives, lip swelling and insomnia. On an unknown date, the patient experienced incomplete course of vaccination. The patient was treated with benadryl (nos) (Benadryl). The action taken with prednisone was unknown. On an unknown date, the outcome of the hives, lip swelling and insomnia were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the hives, lip swelling and insomnia to be related to Shingrix.  Additional details were provided as follows: The patient self reported this case. The age at vaccination was not applicable for 2nd dose of Shingrix. The patient received his first dose of Shingrix into his right arm at his pharmacy and within 12 hours of receiving the injection, he began to experience hives on his hands and torso, and swelling around his lips. The patient went to the urgent care the next day and his physician started him on prednisone.  After 3 days with no relief from hives while on prednisone and due to the insomnia the patient was now experiencing, the physician told him to take Benadryl.  On the fourth day after the injection and after taking the Benadryl, the hives and swelling resolved.  The patient was hesitant about getting the 2nd dose of his Shingrix vaccine after his reaction, the 6 month window for the second dose had passed. Till the time of reporting, the patients did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The patient did not had the lot or expiration date of the vaccine administered. The reporter consented to follow-up. It was unknown if the reporter considered the hives, lip swelling and insomnia to be related to Prednisone.
Mild diarrhea; nausea; This is a spontaneous report received from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN) via an unspecified route administration in left arm on 19Mar2021 at 16:15 (at the age of 51-years-old) as a single dose, for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested positive for COVID-19. Concomitant medication included ibuprofen (MANUFACTURER UNKNOWN) from an unknown date for unknown indication and unknown if ongoing. The patient did not receive any other vaccines within two weeks prior to the vaccination. On 20Mar2021 at 17:00, 24 hours after vaccine was administered, the patient experienced mild diarrhea and nausea for 6 hours. The patient did not receive any treatment for the events mild diarrhoea and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events nausea and diarrhoea was recovered on an unknown date.   Information about lot/batch number cannot be obtained. No further information expected.
I took my son to the doctor after he experienced pink eye, and he was prescribed eye drops to treat the condition. He also had congestion in the days following up to getting pink eye.
Per MD note, patient had fever, fatigue, headache after Pfizer on 7/27/22
VERY EXTREME DIZZINESS. CAN NOT LOOK UP, DOWN, SIDE-TO-SIDE WITHOUT GRIPPING SOME WALL, TABLE, CHAIR. FEEL LIKE I COULD FALL
Customer Safety Compromised: Pregnant/Nursing Mother-Flu vaccination give to pregnant/nursing mother per doctors note.
Sunday it really got sore, swollen, red and hot. Pt also ran a fever until 09/27/2011. Pt was taking Omnicef for infection.
Skin allergic reaction on my face, chest, neck, and hair line a few weeks into receiving the vaccine.  Red burning skin reaction and rash.  These reactions have been repeating in my life ever since receiving the vaccine.  The treatment was an ER visit then have been following up with my dermatologist, allergy doctor and rheumatologist since.  This has been ongoing so 1 year now.
Small Blisters on leg, left arm and hand; This non-serious case was reported by a consumer via call center representative and described the occurrence of blister in a 75-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had shingles 4 years ago from reporting, pre existing the Shingrix vaccine, and it was painful).   On 06-MAY-2023, the patient received the 1st dose of Shingrix (injection, left arm). On 07-MAY-2023, 1 days after receiving Shingrix, the patient experienced blister (Verbatim: Small Blisters on leg, left arm and hand). The outcome of the blister was not resolved.   It was unknown if the reporter considered the blister to be related to Shingrix.     It was unknown if the company considered the blister to be related to Shingrix.   Additional Information: GSK Receipt Date: 08-MAY-2023 The case was self-reported by the patient. The patient reported that yesterday (day before reporting), a new blister showed up on patient's leg (unknown which leg). Two days later of vaccination, the patient had 2 to 3 small blisters on her left arm and hand that had now dried up and were just pink. The reporter did not consent to follow up.
arm pain; This is a spontaneous report received from a contactable reporter (healthcare professional).  An 88 year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administered in left arm, administration date 05Mar2021 11:30 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset Mar2021, outcome "recovered" (Mar2021), described as "arm pain".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Developed Shingles along left back extending around to left chest wall 2 weeks after receiving pfizer covid booster; Interchange of vaccine products; Booster; This is a spontaneous report received from a contactable reporter(s) (Physician). The reporter is the patient.  A 48 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 12Nov2021 18:00 (Lot number: FH8030) at the age of 48 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "High cholesterol" (unspecified if ongoing); "Arthritis" (unspecified if ongoing). Concomitant medication(s) included: ATORVASTATIN; ASPIRINE; VITAMIN D [ERGOCALCIFEROL]; TURMERIC [CURCUMA LONGA]. Vaccination history included: Moderna (Dose Number: 2, Batch/Lot No: 029L20A, Location of injection: Arm Right, Vaccine Administration Time: 02:00 PM), administration date: 20Jan2021, when the patient was 47 years old, for Covid-19 Immunization; Moderna (Dose Number: 1, Batch/Lot No: 011J20A, Location of injection: Arm Left, Vaccine Administration Time: 02:00 PM), administration date: 23Dec2020, when the patient was 47 years old, for Covid-19 Immunization. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (non-serious) with onset 12Nov2021, outcome "unknown", described as "Interchange of vaccine products"; IMMUNISATION (non-serious) with onset 12Nov2021, outcome "unknown", described as "Booster"; HERPES ZOSTER (non-serious) with onset 26Nov2021 15:00, outcome "not recovered", described as "Developed Shingles along left back extending around to left chest wall 2 weeks after receiving pfizer covid booster". The event "developed shingles along left back extending around to left chest wall 2 weeks after receiving pfizer covid booster" was evaluated at the physician office visit. Therapeutic measures were taken as a result of herpes zoster.  Additional information: patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19 and Since the vaccination, patient has not been tested for COVID-19. Ae was treated with Valaciclovir.  No follow-up attempts are possible. No further information is expected.  Follow-Up (02Dec2021): Follow-up attempts are completed. No further information is expected.
Patient received IPV and Varicella vaccines in right deltoid region at two separate sites.  On 3/27 patient returned to office with erythema, swelling, and mild warmth to right deltoid area. Area also indurated.  Affected area is 23 cm in diameter and 7 cm in length.  Treated with cool compresses and Benadryl for itching.
Patient receive a covid19 moderna vaccine on 2/12/21 , on 2/15/21 she had facial swelling, heart racing on 2/16/21 she had blood pressure over 200 and was admitted to emergency room.
Initial and follow up information has been received from a physician and a licensed practical nurse concerning a 68 year old female patient with drug hypersensitivity to codeine and no medical history reported, who on 28-MAY-2008 was vaccinated intramuscularly with a 0.5 ml dose of PNEUMOVAX 23 (Lot # 658074/0803U). Concomitant therapy included LESCOL, DIOVAN, calcium (unspecified), omeprazole, glucosamine, XALATAN eyedrops, LEVOTHROID and LACTAID CAPLETS. On 29-MAY-2008 the patient developed a fever of 100.6 Fahrenheit, body aches, chills, and a local reaction at the injection site on the left arm. On 30-MAY-2008 the patient sought medical attention during an office visit. The fever was gone, but she was still achy and felt bad. The left arm was red and swollen. Her throat and chest were clear. Her neck was supple with no masses. Respirations were not compromised. The patient was treated with TYLENOL. She did not know if this was her first dose of PNEUMOVAX 23. Subsequently, the patient recovered. No product quality complaint was involved. No further information is available.
RN attempted to inject vaccine into left deltoid but syringe leaked and no vaccine was delivered.  A new syringe was obtained and the vaccine was successfully delivered.
Patient wife came in to pick up to pick up antibiotic on patient on Sunday December 22 2019. Wife states patient arm was swollen from receiving two injections(flu and pneumonia) on Tuesday. Patient was taken to hospital were physician state his arm was infection with tender lymph nodes surrounding the area. Left arm was red, hot to touch, and tender.  Patient was prescribed doxycycline for 10 days.
Needed vaccinations prior to cochlear implant surgery. As clinic location is distant from home, I had all 3 needed injected at the same time. Rt. upper arm had Tdap & influenza injections as is still remarkably painful after nearly 4 months.
got diabetic ulcer infection on her foot before she got the vaccine, it got infected and irritated before she took the shot. However, it got irritated again after the first dose; got diabetic ulcer infection on her foot before she got the vaccine, it got infected and irritated before she took the shot. However, it got irritated again after the first dose; This is a spontaneous report received from a contactable other healthcare professional (who is also the patient) via a Pfizer-sponsored program. A female patient of an unspecified age received the first dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number and expiry date unknown), via an unspecified route of administration, on an unspecified date, at single dose, for COVID-19 immunization. Medical history included diabetic ulcer infection on her foot before she got the vaccine, it got infected and irritated before she took the shot on an unspecified date. The patient's concomitant medications were not reported. The patient stated that she got a diabetic ulcer infection on her foot before she got the vaccine, it got infected and irritated before she took the shot. However, it got irritated again after the first dose on an unspecified date.  The patient reported she was scheduled to get the second dose on 26Jan2021 (tomorrow) and she was getting ready to start antibiotic on 25Jan2021 (today). She asked if she can take her antibiotic because she will be getting her second dose. The outcome of the events was unknown.  Information about the lot/batch number has been requested.
This spontaneous report was received from a certified medical assistant and refers to a 13 year old male patient. Information on the patient's concurrent conditions, medical history or concomitant medications was not reported. On 22-APR-2016 at 15:14, the patient was vaccinated with GARDASIL 9 (lot # M004116, expiration date: 12-OCT-2017) dose 1, intramuscularly in the right arm. On unspecified date, the vaccine that was administered to the patient had been improperly stored by being exposed to temperature: 34F for a total time of 65 hours. There were no previous temperature excursions. No adverse event, signs or symptoms were reported. The patient has no illnesses at time of vaccination. This is one of several reports received from the same sources. Additional information is not expected as all available information was obtained.
the pain is terrible, it hurts a lot to move my arm; the pain is terrible, it hurts a lot to move my arm; arm started to hurt; pain is were the vaccine was injected; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: ER8733) via an unspecified route of administration in the left arm on 25Mar2021 at 13:30 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 04Mar2021 at 13:30 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Prior to vaccination, patient was not diagnosed with COVID-19; Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15Apr2021, the patient's arm started to hurt (pain was where the vaccine was injected) and on 16Apr2021, the pain was terrible and it hurt a lot to move arm. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event arm started to hurt, the pain was terrible, it hurt a lot to move arm, pain was where the vaccine was injected were not recovered at the time of report.  No follow-up attempts are needed. No further information is expected.
Pt presented with some isolated hives on face, injection side left deltoid area slightly raised and warm to touch. Member presents to medical 45mins after injection given. Pt was observed for 30 mins and triaged to the medical center for evaluations.
Customer had originally received Moderna on 3/23/2021 and was given Pfizer as the second dose today
This spontaneous report was received from a certified medical assistant and refers to a child of unknown age and gender. The patient's pertinent medical history, concurrent conditions and concomitant medications were not reported. On 31-AUG-2015, the patient was vaccinated with an improperly stored dose of M-M-R II, (lot # L007578 with an expiration date on 05-MAR-2017; dose and route of administration were not provided). No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information is not expected because there was no consent for further contact.
The same night that I received the second shot of the Moderna vaccine my right toes were red itchy and swollen. They were also red itchy and swollen the next day. This happened again another time in the last week. On 3/20 9 days from receiving the vaccine I noticed that my right eye is also swollen.
1/13/2021 at 3:11 pm EMT was alerted to client in observation area.  Client was lethargic and complained of dizziness and feeling sick.  Client brought to medic area.  EKG and B/P and blood sugar taken.  Client diaphoretic.
After the second shot, my calves began to tighten and felt sore most of the time. Over the course of a few days, the pain wouldn't go away. My walking distance before feeling sore began to turn shorter. We went to my physician and my blood pressure was at 168/90. They didn't think much of it and thought the blood pressure machine was broken. Few weeks later, we go again. My blood pressure was still high and my feet were going numb after walking.
I felt fine after the vaccine and I took a walk. Three hours later I got a massive headache. I was nauseous with vomiting and diarrhea. I felt like had bubbles going up my spine when I was lying down about a week after the vaccine. The nausea and vomiting went on for ten hours.  After five weeks my arm is still a little slow I still have headaches intermittently, and sometimes daily.